Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives.

Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on advances in cellular and molecular biology. The Company operates in human therapeutics. It markets human therapeutic products in the areas of supportive cancer care,... more

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer. The Company focuses on two systems for treating cancer: growth factor blockers and angiogenesis... more

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company’s products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab),... more

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada,... more

MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its pipeline... more

Geron Corporation (Geron) is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The Company is advancing telomerase targeted therapies, including an anti-cancer drug and a cancer vaccine,... more

Cephalon, Inc. is an international biopharmaceutical company engaged in the discovery, development and marketing of products to treat human diseases. The Company’s focuses its efforts in four core therapeutic areas: central nervous system (CNS) disorders, pain, cancer and addiction. In... more

QLT Inc. is a global biopharmaceutical company with two commercial products, Visudyne and Eligard, which were derived from its two technology platforms, photodynamic therapy and Atrigel. The Company's research and development efforts are focused on pharmaceutical products in the fields of... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

CytRx Corporation (CytRx) is a clinical-stage biopharmaceutical company engaged in developing human therapeutic products based primarily upon its small-molecule molecular chaperone amplification technology. As of December 31, 2007, the Company is using its chaperone amplification... more

ADVENTRX Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates primarily for the treatment of cancer and infectious disease. The Company is focused primarily on advancing ANX-530 and ANX-514, which are emulsion... more

GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these... more

EPIX Pharmaceuticals, Inc. (EPIX) is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products. EPIX has four internally discovered therapeutic product candidates in clinical trials. These drug candidates are PRX-00023 for depression,... more

Telik, Inc. is a biopharmaceutical company working to discover, develop and commercialize small molecule drugs to treat diseases. The Company discovered its product candidates using its drug discovery technology, Target-Related Affinity Profiling (TRAP). As of December 31, 2007, Telik has... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

InterMune, Inc. (InterMune) is a biotech company focused on developing and commercializing therapies in pulmonology and hepatology. As of December 31, 2007, the Company’s development programs included pirfenidone for pulmonary fibrosis (IPF), the hepatitis C virus (HCV) protease inhibitor... more

Insmed Incorporated (Insmed) is a development stage biopharmaceutical company specializing in recombinant protein drug development. The Company is developing a pipeline of products targeted at the therapeutic areas of autoimmune, neutropenia and anemia. On the protein front, Insmed’s... more

CAT is a biopharmaceutical company aiming to bring improvements to seriously ill patients' lives and in this way create outstanding returns for shareholders. The company seeks to develop high value products in which it has a significant economic interest, both independently and in... more

Scios, a member of the Johnson & Johnson Family of Companies, provides a wide range of benefits for you and, where applicable, for your eligible dependents. Keeping with its commitment to employees, Scios offers a comprehensive compensation and benefits package. The programs outlined... more

Renovis is now a wholly owned subsidiary of Evotec, AG. You will be redirected to the Evotec web site momentarily.

Momenta Pharmaceuticals, Inc. (Momenta) is a biotechnology company with a product pipeline of mixture generic drugs. Momenta characterizes the structure and structure-process of mixture drugs to develop generic versions of marketed products. The Company's most advanced product candidate... more

Sunesis Pharmaceuticals, Inc. (Sunesis) is a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of small molecule therapeutics for use in oncology and other diseases. As of December 31, 2007, the Company was advancing three... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

ImmunoGen, Inc. is focused on the development of antibody-based anticancer therapeutics. The Company’s Tumor-Activated Prodrug (TAP) technology uses antibodies to deliver a potent cytotoxic agent specifically to cancer cells. The antibody component enables a TAP compound to bind... more

Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead product candidate, PDX (pralatrexate) an antifolate is in Phase 2 trial in patients with relapsed or refractory... more

BioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises three products and multiple investigational product candidates. Approved products include Naglazyme (galsulfase), Kuvan... more

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage, biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the... more

Alkermes, Inc (Alkermes) is a biotechnology company. The Company manufactures RISPERDAL CONSTA for schizophrenia and developed and manufacture VIVITROL for alcohol dependence. Alkermes ia a long-acting formulation of risperidone, a product of Janssen Pharmaceutica, Inc., a division of... more

Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta’s research portfolio consists... more

Tanox is a growing biotechnology company with great career opportunities. We are headquartered in Houston, Texas near the world-renowned Texas Medical Center. We also maintain a manufacturing facility in San Diego, California.

Altus Pharmaceuticals Inc. (Altus) is a biopharmaceutical company focused on the development of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders, with three product candidates in clinical development. The Company uses its protein crystallization... more

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The Company's product candidates address pharmaceutical markets in the world, including endometriosis, irritable bowel syndrome, anxiety, depression,... more

Encysive Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. Encysive has undergone a cultural evolutionfrom a research and development boutique to a... more

Domantis Limited develops the next generation of antibody molecules: Human Domain Antibodies. Domain AntibodiesÔ (dAbsÔ) are therapeutic molecules that have benefits of both small molecules and conventional antibodies. Like small molecules, dAbs are small in size and highly stable,... more

Valentis is focused on the creation of innovative cardiovascular therapeutics. The Company begins its product development at the stage of a known molecule or protein and applies its expertise in formulation, manufacturing, clinical development and regulatory affairs to create products... more

MorphoSys is one of the world's leading biotechnology companies focusing on fully human antibodies. With its proprietary technologies, MorphoSys is developing not only the next generation of therapeutic antibodies, but also antibodies for research and diagnostics purposes. HuCAL® (Human... more

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small molecule drugs that modulate ion channel targets. The Company has identified drug candidates that modulate ion channels. Its two most advanced programs are... more

Inhibitex, Inc. is a biopharmaceutical company focused on the development of differentiated anti-infective products. It pursues pre-clinical or clinical-stage antiviral development programs via in-licensing or acquisition. On September 19, 2007, the Company completed the acquisition of... more

Adolor Corporation is a development-stage biopharmaceutical company. The Company has specialized in the discovery and development of prescription pain management products. It has a number of product candidates in various stages of development, ranging from preclinical studies to pivotal... more

Replidyne, Inc. is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing anti-infective products. Its most advanced product candidate, faropenem medoxomil, is an oral, community antibiotic being developed for adult primary care and pediatric... more

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with exclusive worldwide commercial rights to three product candidates in clinical development. The Company’s... more

Trubion Pharmaceuticals, Inc. (Trubion) is a biopharmaceutical company creating a pipeline of protein therapeutic product candidates to treat autoimmune and inflammatory diseases, and cancer. The Company’s product candidates are small modular immunopharmaceuticals or SMIP, therapeutics... more

Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for short stature and other metabolic disorders.

Nuvelo, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. The Company’s development pipeline includes alfimeprase, a direct-acting fibrinolytic in... more